JAZZ PHARMACEUTICALS, INC. for JAZZ PHARMACEUTICALS, INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R.1996 - SAFE Banking Act of 2021 Cannabis Administration & Opportunity Act Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement. FDA regulation of cannabis-derived products
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARAS GROSS New | FDA - Associate Commissioner for Legislative Affairs (2019-20); House Rules Committee - Deputy Staff Director (2011-19); House Judiciary Committee - Deputy Parliamentarian (2008-11); House of Representatives - Sr. Legislative Assistant (2004-08) |
| VIRGINIA MCMILLIN | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.